Literature DB >> 11350836

Lipopolysaccharide inhibits the late-phase response to allergen by altering nitric oxide synthase activity and interleukin-10.

M K Tulić1, D A Knight, P G Holt, P D Sly.   

Abstract

We have previously shown that exposure of sensitized animals to lipopolysaccharide (LPS) 18 h after ovalbumin (OVA) challenge inhibits late-airway response (LAR). Using relatively selective nitric oxide synthase (NOS) inhibitors we have shown that LPS upregulates inducible NOS (iNOS) and downregulates constitutive NOS (cNOS) activity. In this study we set out to quantitate NOS isoenzyme activity in lung homogenates and to measure ex vivo interleukin (IL)-10 in tracheal explants of naive or sensitized and OVA-challenged rats exposed to LPS. iNOS activity was increased and cNOS activity reduced 6 h after LPS exposure in naive animals (n = 6, P < 0.001) and at 18 (n = 5, P < 0.001) or 24 (n = 5, P < 0.001) h after OVA challenge in sensitized animals. LPS exposure 18 h after OVA challenge in sensitized animals reversed OVA-induced changes in NOS isoenzyme activities (n = 5, P < 0.001). In naive animals IL-10 was increased 1 h after LPS exposure (n = 5, P < 0.001), peaked at 3 h (n = 9, P < 0.001), and remained elevated above baseline at 18 h (n = 11, P < 0.05). In sensitized animals, IL-10 was not increased until 18 h after OVA challenge (n = 11, P < 0.001). Due to the rapid IL-10 increase in naive animals the released IL-10 is likely to be preformed; however, in sensitized animals the results are consistent with de novo production of IL-10. In the sensitized and OVA-challenged group, exposure to LPS 18 h after OVA produced a 3-fold increase in IL-10 at 3 h after LPS exposure (n = 5, P < 0.001). The time course and kinetics of IL-10 release in those animals was similar to that seen in naive rats. These results support our previous conclusions on the basis of in vivo studies using isoenzyme inhibitors and have shown LPS to be able to reverse OVA-induced changes in NOS isoenzyme activities during an established LAR. LPS-induced release of IL-10 is thought to play an important immunomodulatory role in this model.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350836     DOI: 10.1165/ajrcmb.24.5.4265

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

Review 1.  Maternal influences over offspring allergic responses.

Authors:  Joan M Cook-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806

2.  Asthma, allergy and vitamin E: Current and future perspectives.

Authors:  Joan M Cook-Mills; Samantha H Averill; Jacquelyn D Lajiness
Journal:  Free Radic Biol Med       Date:  2021-11-14       Impact factor: 8.101

3.  Evaluating the suitability of using rat models for preclinical efficacy and side effects with inhaled corticosteroids nanosuspension formulations.

Authors:  Po-Chang Chiang; Yiding Hu; Jason D Blom; David C Thompson
Journal:  Nanoscale Res Lett       Date:  2010-04-10       Impact factor: 4.703

4.  Interleukin-12-independent down-modulation of cockroach antigen-induced asthma in mice by intranasal exposure to bacterial lipopolysaccharide.

Authors:  Steven K Lundy; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

5.  Accumulation mode particles and LPS exposure induce TLR-4 dependent and independent inflammatory responses in the lung.

Authors:  Angela M Fonceca; Graeme R Zosky; Elizabeth M Bozanich; Erika N Sutanto; Anthony Kicic; Paul S McNamara; Darryl A Knight; Peter D Sly; Debra J Turner; Stephen M Stick
Journal:  Respir Res       Date:  2018-01-22

Review 6.  Dual Role of Toll-like Receptors in Human and Experimental Asthma Models.

Authors:  Amin Zakeri; Momtchilo Russo
Journal:  Front Immunol       Date:  2018-05-15       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.